The topoisomerase I poison camptothecin generates a Chk1-dependent DNA damage checkpoint signal in fission yeast

Yeast

Volumn 15, Issue 10 A, 1999, Pages 821-828

  Wan, Shanhong ^a   Capasso, Holly ^a   Walworth, Nancy C ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Camptothecin; Checkpoint; Chk1; DNA damage; Schizosaccharomyces pombe

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; DOUBLE STRANDED DNA; PHOSPHOTRANSFERASE;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; DOSE RESPONSE; DRUG CYTOTOXICITY; GENE DISRUPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCHIZOSACCHAROMYCES POMBE; YEAST CELL;

SCHIZOSACCHAROMYCES POMBE;

EID: 0032773824     PISSN: 0749503X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0061(199907)15:10a<821::aid-yea422>3.0.co;2-%23     Document Type: Article

References (34)

1. al-Khodairy, F. and Carr, A. M. (1992). DNA repair mutants defining G2 checkpoint pathways in Schizosaccharomyces pombe. EMBO J. 11, 1343-1350.
2. al-Khodairy, F., Fotou, E., Sheldrick, K. S., Griffiths, D. J. F., Lehmann, A. R. and Carr, A. M. (1994). Identification and characterization of new elements involved in checkpoint and feedback controls in fission yeast. Mol. Biol. Cell 5, 147-160.
3. Boddy, M. N., Furnari, B., Mondesert, O. and Russell, P. (1998). Replication checkpoint enforced by kinases Cds1 and Chk1. Science 280, 909-912.
4. Covey, J. M., Jaxel, C., Kohn, K. and Pommier, Y. (1989). Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Cancer Res 49, 5016-5022.
5. D'Arpa, P., Beardmore, C. and Liu, L. F. (1990). Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res 50, 6919-6924.
6. Elledge, S. J. (1996). Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664-1672.
7. Eng, W-K., Faucette, L., Johnson, R. K. and Sternglanz, R. (1988). Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol. Pharmacol. 34, 755-760.
8. Gallo, R. C., Whang-Peng, J. and Adamson, R. H. (1971). Studies on the antitumor activity, mechanism of action and cell cycle effects of camptothecin. J. Natl Cancer Inst. 46, 789-795.
9. Harlow, E. and Lane, D. (1988). Antibodies, A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York.
10. Hartwell, L. H. and Weinert, T. A. (1989). Checkpoints: controls that ensure the order of cell cycle events. Science 246, 629-634.
11. Hertzberg, R. P., Caranfa, M. J. and Hecht, S. M. (1989). On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry 28, 4629-4638.
12. Holm, C., Covet, J. M., Kerrigan, D. and Pommier, Y. (1989). Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res 49, 6365-6368.
13. Horiguchi, T. and Tanida, S. (1995). Rescue of Schizosaccharomyces pombe from camptothecinmediated death by a DNA topoisomerase I inhibitor, TAN-1518 A. Biochem. Pharmacol. 49, 1395-1401.
14. Hsiang, Y.-H., Hertzberg, R., Hecht, S. and Liu, L. F. (1985). Camptothecin induces protein-linked DNA breaks in mammalian DNA topoisomerase I. J. Biol. Chem. 260, 14 873-14 878.
15. Hsiang, Y.-H., Lihou, M. G. and Liu, L. F. (1989). Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 49, 5077-5082.
16. Kauh, E. A. and Bjornsti, M.-A. (1995). SCT1 mutants suppress the camptothecin sensitivity of yeast cells expressing wild-type DNA topoisomerase I. Proc. Natl Acad. Sci. U S A 92, 6299-6303.
17. Levin, N. A., Bjornsti, M.-A. and Fink, G. R. (1993). A novel mutation in DNA topoisomerase I of yeast causes DNA damage and RAD9-dependent cell cycle arrest. Genetics 133, 799-814.
18. Lindsay, H. D., Griffiths, D. J. F., Edwards, R. J., Christensen, P. U., Murray, J. M., Osman, F., Walworth, N. and Carr, A. M. (1998). S-phase-specific activation of Cds1 kinase defines a sub-pathway of the checkpoint response in Schizosaccharomyces pombe. Genes Dev. 12, 382-295.
19. Liu, L. F. (1989). DNA topoisomerase poisons as antitumor drugs. Ann. Rev. Biochem. 58, 351-375.
20. Liu, L. F. and Wang, J. C. (1991). Biochemistry of DNA topoisomerases and their poisons. In Potmesil, M. and Kohn, K. W. (Eds), DNA Topoisomerases in Cancer. Oxford University Press, Oxford, pp. 13-22.
21. Lydall, D. and Weinert, T. (1995). Yeast checkpoint genes in DNA damage processing: implications for repair and arrest. Science 270, 488-491.
22. Moreno, S., Klar, A. and Nurse, P. (1991). Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Methods Enzymol. 194, 795-823.
23. Nitiss, J. and Wang, J. C. (1988). DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc. Natl Acad. Sci. U S A 85, 7501-7505.
24. O'Connell, M. J., Raleigh, J. M., Verkade, H. M. and Nurse, P. (1997). Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J. 16, 545-554.
25. Peng, C. Y., Graves, P. R., Thoma, R. S., Wu, A., Shaw, A. S. and Piwnica-Worms, H. (1997). Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501-1505.
26. Porter, S. E. and Champöux, J. J. (1989). The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I. Nucleic Acids Res. 17, 8521-8532.
27. Rhind, N., Furnari, B. and Russell, P. (1997). Tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev. 11, 504-511.
28. Ross, W. E. (1985). DNA topoisomerases as targets for cancer therapy. Biochem. Pharmacol. 34, 4191-4195.
29. Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H. and Elledge, S. J. (1997). Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277, 1497-1501.
30. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Paranjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S. and Shiloh, Y. (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753.
31. Tsao, Y.-P., Russo, A., Nyamuswa, G., Silber, R. and Liu, L. F. (1993). Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res. 53, 5908-5914.
32. Walworth, N., Davey, S. and Beach, D. (1993). Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2. Nature 363, 368-371.
33. Walworth, N. C. and Bernards, R. (1996). rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint. Science 271, 353-356.
34. Weinert, T. (1997). A DNA damage checkpoint meets the cell cycle engine. Science 277, 1450-1451.